Hochschulschrift
Apoptoseinduktion durch Chemotherapeutika wie u.a. Cladribin und Gemcitabin auf CD34+-CD38+- und CD34+-CD38--Vorläuferzellen : selektiver protektiver Effekt von Doxorubicin und Cladribin auf hämatopoetische Stammzellen
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
21 cm
- Extent
-
120 S.
- Language
-
Deutsch
- Notes
-
graph. Darst.
Frankfurt (Main), Univ., Diss., 2007
- Keyword
-
Krebs
Onkologie
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:57 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia
Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones
CD45dimCD34+CD38−CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia
Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized
Targeting of CD34+CD38-cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia
Prognostic Impact of the CD34+/CD38- Cell Burden in Patients with Acute Myeloid Leukemia receiving Allogeneic Stem Cell Transplantation
Die prätherapeutische CD34+/CD38- Zelllast im Knochenmark als prognostischer Faktor bei Patienten mit Myelodysplastischem Syndrom, die eine allogene Stammzelltransplantation erhalten
Plastic CD34 and CD38 expression in adult B-cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations
Direct confirmation of quiescence of CD34+CD38- leukemia stem cell populations using single cell culture, their molecular signature and clinicopathological implications
Unterschiedlicher Anstieg von CD34-, KDR/CD34-, CD133/CD34- und CD117/CD34-positiven Zellen im peripheren Blut von Patienten mit akutem Myokardinfarkt
CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection
CD38 promotes hematopoietic stem cell dormancy
CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia
Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones
CD45dimCD34+CD38−CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia
Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized
Targeting of CD34+CD38-cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia
Prognostic Impact of the CD34+/CD38- Cell Burden in Patients with Acute Myeloid Leukemia receiving Allogeneic Stem Cell Transplantation
Die prätherapeutische CD34+/CD38- Zelllast im Knochenmark als prognostischer Faktor bei Patienten mit Myelodysplastischem Syndrom, die eine allogene Stammzelltransplantation erhalten
Plastic CD34 and CD38 expression in adult B-cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations
Direct confirmation of quiescence of CD34+CD38- leukemia stem cell populations using single cell culture, their molecular signature and clinicopathological implications
Unterschiedlicher Anstieg von CD34-, KDR/CD34-, CD133/CD34- und CD117/CD34-positiven Zellen im peripheren Blut von Patienten mit akutem Myokardinfarkt
CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection
CD38 promotes hematopoietic stem cell dormancy
CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia
Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones
CD45dimCD34+CD38−CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia
Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized
Targeting of CD34+CD38-cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia
Prognostic Impact of the CD34+/CD38- Cell Burden in Patients with Acute Myeloid Leukemia receiving Allogeneic Stem Cell Transplantation
Die prätherapeutische CD34+/CD38- Zelllast im Knochenmark als prognostischer Faktor bei Patienten mit Myelodysplastischem Syndrom, die eine allogene Stammzelltransplantation erhalten
Plastic CD34 and CD38 expression in adult B-cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations
Direct confirmation of quiescence of CD34+CD38- leukemia stem cell populations using single cell culture, their molecular signature and clinicopathological implications
Unterschiedlicher Anstieg von CD34-, KDR/CD34-, CD133/CD34- und CD117/CD34-positiven Zellen im peripheren Blut von Patienten mit akutem Myokardinfarkt
CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection